CTRI/2021/08/035450
Recruiting
未知
Concordance study of Circulating Tumor Cells (CTCs) with Biopsy in Patients with newly diagnosed Lung Cancer
ConditionsHealth Condition 1: C00-D49- Neoplasms
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Sponsor
- Datar Cancer Genetics Private Limited
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Provision of signed dated informed consent form.
- •Suspected to have malignancy or newly diagnosed for lung malignancy(therapy naÃ?¯ve)
Exclusion Criteria
- •Failure to meet any or all of the above criteria.
- •Positive for HIV, HBV, HCV, or tuberculosis.
- •Received any type or anticancer treatment since diagnosis; includes systemic therapy, radiation or surgery.
- •Received blood transfusion within last 30 days.
- •Underwent PET\-CT scan within last 5 days.
- •Unable to undergo tissue biopsy as part of Standard diagnostic Workup.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Analysis of circulating tumor cells(CTCs) and clinical significance of CTCs; human atrial natriuretic peptide during perioperative period for completely resected non-small cell lung cancer: a multicentre, open-label, randomised controlled trialnon-small cell lung cancerJPRN-UMIN000024302Osaka University Graduate School of Medicine500
Completed
Not Applicable
Observational study in hepatocellular carcinoma (Liver Disease)Health Condition 1: null- HepatoCellular CarcinomaHealth Condition 2: K746- Other and unspecified cirrhosis ofliverCTRI/2018/02/011987Institute of liver and Biliary Sciences53
Active, not recruiting
Not Applicable
Evaluation of Circulating Tumors Cells (CTCs) as Potential Surrogate Marker for Further Definition und Subclassification of non metastatic High-Risk Castration Resistant Prostate Cancer Patientsprostate cancerC61Malignant neoplasm of prostateDRKS00008554OnkoDataMed GmbH5
Recruiting
Not Applicable
Determining Circulating Tumour Cells (CTC) and other rare cells in cancer patients and for early detection screeningACTRN12614001143617Dr Karin Ried2,000
Completed
Not Applicable
Detection of circulating tumor cells (CTC) with novel viral marker (OBP-401) for patients with prostate cancerProstate cancerJPRN-UMIN000010410Department of Urology, Kobe university graduate school of medicine50